Cystatin B (CstB), encoded on chromosome 21, is an endogenous inhibitor of cathepsin B. Down syndrome patients show increased expression of CstB, which correlates with early-onset AD risk [78]. This evidence concerns the gene CTSB and Alzheimer disease.